FENC   $5.91  -2.80% Market Closed After Close 5.91 0.0

Fennec Pharmaceuticals Inc
Last Events:

2023-08-09 Trend pattern changed from восходящий треугольник to симметричный треугольник.

2023-08-06 Trend pattern changed from расходящийся клин с наклоном вверх to восходящий треугольник.

2023-08-06 Signal in Stochastic changed from bearish reversal to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

2023-08-06 Signal in RSI changed from bearish to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-05 Signal in Stochastic changed from bullish to bearish reversal. The stochastic indicator is in the upper part of the neutral territory and left the overbought territory. These factors indicate that perhaps the upside trend is coming to an end price will probably head south Last signal: main and signal line crossing.

2023-08-05 Signal in MACD changed from bullish reversal to bearish recovery. Oscillator MACD is in the negative territory it's higher than the signal line and falls. These factors mean that negative mood prevails, but this trend does not have a significant strength. Last signal: main and signal line crossing.

2023-08-05 Signal in RSI changed from bullish weakening to bearish. RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

2023-08-05 Signal in EMA100 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.


Current temperature: 0.00
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 5
Target Price Mean 13.600
Mean unverified/preliminary 13.600 / 13.600
Target Price Low / High 12.000 / 15.000
Median / STD DEV 13.000 / 1.34
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy ActivelyBuy Buy
rsi ActivelyBuy ActivelyBuy Buy
macd None None None
stoch ActivelyBuy None None
ma20 Sell Buy None
ma50 None None None
ma100 Buy Buy Buy
Candlestick PatternJan. 10, 2025 Long Legged - consists of a Doji with very long upper and lower shadows. Indicates strong forces balanced in opposition.
ISIN CA31447P1009
ceo Mr. Rostislav Raykov
Website https://www.fennecpharma.com
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.